Quality of National Disease Surveillance Reporting before and during COVID-19: A Mixed-Method Study in Indonesia

Int J Environ Res Public Health. 2022 Feb 26;19(5):2728. doi: 10.3390/ijerph19052728.

Abstract

Background: Global COVID-19 outbreaks in early 2020 have burdened health workers, among them surveillance workers who have the responsibility to undertake routine disease surveillance activities. The aim of this study was to describe the quality of the implementation of Indonesia's Early Warning and Response Alert System (EWARS) for disease surveillance and to measure the burden of disease surveillance reporting quality before and during the COVID-19 epidemic in Indonesia.

Methods: A mixed-method approach was used. A total of 38 informants from regional health offices participated in Focus Group Discussion (FGD) and In-Depth Interview (IDI) for informants from Ministry of Health. The FGD and IDI were conducted using online video communication. Yearly completeness and timeliness of reporting of 34 provinces were collected from the application. Qualitative data were analyzed thematically, and quantitative data were analyzed descriptively.

Results: Major implementation gaps were found in poorly distributed human resources and regional infrastructure inequity. National reporting from 2017-2019 showed an increasing trend of completeness (55%, 64%, and 75%, respectively) and timeliness (55%, 64%, and 75%, respectively). However, the quality of the reporting dropped to 53% and 34% in 2020 concomitant with the SARS-CoV2 epidemic.

Conclusions: Report completeness and timeliness are likely related to regional infrastructure inequity and the COVID-19 epidemic. It is recommended to increase report capacities with an automatic EWARS application linked systems in hospitals and laboratories.

Keywords: COVID-19; disease burden; health care system; public health measures; public health resources.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • COVID-19* / epidemiology
  • Humans
  • Indonesia / epidemiology
  • Population Surveillance* / methods
  • RNA, Viral
  • SARS-CoV-2

Substances

  • RNA, Viral